DNA/RNA Extraction Kit Designed to Simplify Molecular Testing Receives CE-IVD Mark
The kit allows laboratories to extract DNA and RNA from a range of clinical specimens using a single method.
The kit allows laboratories to extract DNA and RNA from a range of clinical specimens using a single method.
Thermo Fisher Scientific has launched the Gibco CHO-K1 Catalog Panel, a cGMP-ready media portfolio that, in internal studies, demonstrated up to 73% higher titer and 202% higher viable cell density in CHO-K1 fed-batch processes.
The FDA has authorized Aletta, the first standalone robotic device for automated blood draws in outpatient settings, allowing one phlebotomist to oversee up to three devices to help address workforce shortages.
Diazyme Laboratories has acquired Carolina Liquid Chemistries, integrating CLC’s chemistry systems and reagents with Diazyme’s diagnostic technologies to expand solutions for reference and clinical laboratories.
Bio-Rad has launched Vericheck ddPCR kits for quality control in cell and gene therapy manufacturing, offering validated workflows for mycoplasma detection, capsid analysis, and residual DNA quantification.
The company showcased its latest automation and informatics platforms designed to improve laboratory efficiency and diagnostic accuracy.
Using microfluidic shear stress, the system detaches living cells from excised tissue to support pathology workflows and downstream diagnostic testing.
A recent NYU study finds 68.6% of US adults now access lab results via online portals before clinician review, with comprehension varying by digital literacy and patient-centered communication.
Emerging hazards like aerosolized chemicals and laser equipment demand upgraded protection.
Caresfield launched the Resilience-Ready Lab initiative at ADLM 2026, introducing products aimed at improving specimen integrity and supply chain resilience to help labs meet 2026 National Performance Goals.